Drug profile · INN
sonrotoclax
BEQALZI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sonrotoclax (BEQALZI) is an FDA-listed pharmaceutical active ingredient. Associated with Beone Medicines Ireland Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sonrotoclax
Brand BEQALZI
Route ORAL
Formulation TABLET
Originator Beone Medicines Ireland Limited
Frequently asked questions
What is sonrotoclax?
sonrotoclax (BEQALZI) is an FDA-listed pharmaceutical active ingredient. Associated with Beone Medicines Ireland Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sonrotoclax?
BEQALZI is a marketed brand name for sonrotoclax. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sonrotoclax?
sonrotoclax has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.